Sulfoxides
Medchemexpress LLC CB2R/FAAH modulator-3 | 2876918-67-9 | C22H31NO2 | 100 MG
CB2R/FAAH modulator-3 (compound 27) is a dual-targeting modulator that acts as a CB2R agonist and FAAH inhibitor. It has Ki values of 20.1 nM for CB2R and 67.6 nM for CB1R, and an IC50 value of 3.4 μM for FAAH.
- Dual-targeting modulator
- Acts as a CB2R agonist
- Acts as a FAAH inhibitor
- Can be used in studies related to cancer
- Can be used in studies related to deleterious inflammatory cascades occurring in neurodegenerative diseases
- Can be used in studies related to COVID-19 infection
Medchemexpress LLC Ramelteon metabolite M-II-d3 | 1246812-22-5 | 99.8% | 278.36 g/mol | C16H18D3NO3 | 5 MG
Ramelteon metabolite M-II-d3 is the deuterium-labeled analog of the major human metabolite of ramelteon, provided as a high-purity reference standard intended for use as a tracer or internal standard in quantitative analytical methods. It is supplied as a solid suitable for laboratory analysis.
- Deuterium-labeled internal standard for quantitative analysis.
- High purity suitable for analytical work.
- Supplied as a white to off-white solid for ease of handling.
- Compatible with NMR, GC-MS, and LC-MS workflows.
- Molecular weight approximately 278.36 g/mol for accurate calculations.
Sigma Aldrich Fine Chemicals Biosciences Methyl sulfoxide >=99%, FG | 67-68-5 | MFCD00002089 | 25KG
Methyl sulfoxide >=99%, FG | Purity: >=99% | Mol Wt: 78.13 | 67-68-5 | MFCD00002089 | 25KG
Medchemexpress LLC Promethazine sulfoxide | 7640-51-9 | MFCD08063694 | 10mg
Promethazine sulfoxide is a metabolite of the histamine H1 receptor antagonist Promethazine (HY-B1296) It is formed from promethazine by the cytochrome P450 (CYP) isoform CYP2D6
![Medchemexpress LLC 1-(2-(dimethylamino)ethyl)-3-(7-methylbenzo[1,2-d:3,4-d']bis(thiazole)-2-yl)urea | 1428729-63-8 | MFCD31619259 | 99.5% | 335.45 | C14H17N5OS2 | 10 MG](https://assets.fishersci.com/TFS-Assets/CCG/product-images/5000242844.png-250.jpg)
Medchemexpress LLC 1-(2-(dimethylamino)ethyl)-3-(7-methylbenzo[1,2-d:3,4-d']bis(thiazole)-2-yl)urea | 1428729-63-8 | MFCD31619259 | 99.5% | 335.45 | C14H17N5OS2 | 10 MG
RIG-1 modulator 1 is a small-molecule research compound described as an antiviral agent with reported activity against influenza virus, hepatitis B virus (HBV), hepatitis C virus (HCV), and human immunodeficiency virus (HIV). It is supplied as a solid for laboratory research; key analytical data include molecular formula C14H17N5OS2 and molecular weight 335.45 g/mol.
Medchemexpress LLC (+)-LRH-1 modulator-1 | 00-00-0 | 99.4% | C28H36N2O2S | 10MG
(+)-LRH-1 modulator-1 is the (+)-stereoisomer of an LRH-1 modulator and functions as a potent agonist of liver receptor homolog-1 (LRH-1). It modulates inflammatory signaling in intestinal organoid models by inducing IL-10 and reducing IL-1β and TNFα. The compound is provided as a high-purity research-grade small molecule for cellular and biochemical studies of LRH-1 pathways.
- Potent LRH-1 modulator/agonist for receptor pharmacology studies.
- Induces anti-inflammatory cytokine IL-10 in organoid models.
- Reduces proinflammatory cytokines IL-1β and TNFα in assays.
- High purity suitable for cellular and biochemical experiments.
- Available in multiple small-scale quantities for research use.
Medchemexpress LLC Kv3.1 modulator 2 | 99.8% | 437.88 | 50 MG
Kv3.1 modulator 2 (compound 4) is a Kv3.1 channels modulator with an EC50 value of 68 nM. This modulator is suitable for laboratory research and studies involving Kv3.1 channels.
- Functions as a Kv3.1 channels modulator
- Has an EC50 value of 68 nM
Medchemexpress LLC IL-17A modulator-3 | 2467732-95-0 | 99.4% | 639.80 | 50 MG
IL-17A modulator-3 (compound 253) is an IL-17A modulator that inhibits IL-17A/A with an IC50 value of less than 10 μM. This compound is suitable for research related to inflammation, cancer, and autoimmune diseases.
- Potent inhibition of IL-17A/A at sub-micromolar concentrations.
- Applicable in studies of inflammatory conditions.
- Useful for cancer research.
- Valuable for investigations into autoimmune diseases.
